Whatever it was- 99.999999999999999999999999999999999999999999999999999999999999999999999999999% new potency assay data ,
agreement on potency assay data makes the Phase lll an adequate and well controlled trial that met it's primary endpoint.
Exciting isn't it- back to the review process - good for you Whytee- ensuring the trial was conducted by the book
woooop wooooooooop
Reg
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L, page-261
-
- There are more pages in this discussion • 125 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.57 |
Change
-0.210(11.8%) |
Mkt cap ! $1.792B | |||
| Open | High | Low | Value | Volume |
| $1.72 | $1.74 | $1.52 | $15.63M | 9.716M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5127 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.57 | 39613 | 3 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |